Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule - Wikidata - wikimedia - TriplyDB

Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule

Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule

http://www.wikidata.org/entity/Q34173426

about

Checkpoint Inhibitors and Their Application in Breast Cancer The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy T cell coinhibition and immunotherapy in human breast cancer Protein mislocalization: mechanisms, functions and clinical applications in cancer.B7-H1 expression associates with tumor invasion and predicts patient's survival in human esophageal cancer Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells.The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer.Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials.Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer.Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling.The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus.Therapeutic targeting of B7-H1 in breast cancer.PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.Chemoimmunotherapy: reengineering tumor immunity.Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?Tackling breast cancer chemoresistance with nano-formulated siRNA.DNA Damage and Repair Biomarkers of Immunotherapy Response.Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients.PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation.Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment.Relationship Between PD-L1 Expression and Clinical Characteristics in Patients with Breast Invasive Ductal Carcinoma.PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways.Combining DNA damaging therapeutics with immunotherapy: more haste, less speed.Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.Imaging PD-L1 Expression with ImmunoPET.Decreased Survival After Combining Thoracic Irradiation and an Anti-PD-1 Antibody Correlated With Increased T-cell Infiltration Into Cardiac and Lung Tissues.Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice.PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?From Benchtop to Bedside: A Review of Oncolytic Virotherapy.Relationship Between PD-L1 Expression and Clinical Characteristics in Patients with Breast Invasive Ductal Carcinoma.Atezolizumab for the First-Line Treatment of Non-small Cell Lung Cancer (NSCLC): Current Status and Future Prospects

P2860

Q26745442-780E4217-A17E-4FE6-935B-B1A7E8E0FEEE Q26766066-007A1F2D-C5F7-40C9-864E-CC2E04EA0CC7 Q26863779-93593D51-151D-49FE-B486-2D0D517E8CF4 Q28076473-B2FCFF2C-3B0F-4D50-B64C-BCF8AB3F11BC Q33936154-F8605103-C66C-4B16-9D10-F4E57EE51988 Q34076405-37BFAEB8-147D-49DF-AA35-1A06F58143CB Q34371536-332415EB-EA65-4744-8471-37115D6B51E6 Q35159355-3B759D67-E99B-4C7A-8F9E-296378F03A29 Q35399165-568BD690-1EF7-4539-B12C-8E8AD8E6A2DD Q35849100-42F09790-B7A5-4732-870E-531539E4955D Q36288987-2B15ACDB-2412-4E74-B3AF-C2483002812F Q36517199-46BA80C7-1133-4A45-9EB6-B71F82CA91A4 Q36653524-C17B6131-C23E-4EA2-A199-A9C6295EC7E3 Q37346163-3921DB9B-17B8-4626-B37D-ACD1824839C1 Q37422094-2A7A960D-7052-4405-918F-3E004B8DDC19 Q37501853-5DA308A4-5AD3-444C-B3A3-3F1371F5FBDF Q37922793-BAEE1606-18ED-4648-BED3-BE414C6B4464 Q37951937-A408A7CA-5E84-45D7-9733-5097A3B88D1F Q38079749-C07E1552-118C-49D3-8157-3C2AD279252F Q38223419-F64B5EE4-79A5-43FC-944C-863FF060E1FD Q38912004-3116A86F-4314-4C77-9778-94452CB11F1C Q38959517-3647FAC7-0510-4F40-9E1F-1D233CF95F60 Q39384263-E92CEC61-E03B-4E92-B5CB-2B7F473983CD Q39641921-FAB1D947-1C54-41F7-B75E-BE702AE44117 Q40160069-9799A230-8AF9-4357-A794-62D307828EA3 Q44891305-37C7977F-DAF2-41DB-A953-DADD0BE2FDE4 Q46871198-89B123C6-0DD1-4E45-BBCB-74794B3ABCEB Q47289144-8AFCFABF-B0EF-4E06-8CE1-B60C63E5D2BC Q47621538-6EC6044D-EFC6-40F2-891D-58F55387BEF6 Q48307824-4342A41C-8CCC-4F7A-9C93-9BB411605DBA Q48324917-931733E5-9687-4D8D-AED1-9EE2485587A6 Q49815979-B7F76828-465D-486F-AE02-DA922B079764 Q50042048-160D63BE-64E1-477F-9651-5F23A6380B59 Q50433337-43423DD5-FEC2-42B9-9DC4-207531225CEB Q53272922-74A68056-8AE5-400F-936B-0DA631217FDB Q54127836-5FFE2363-5A59-4203-90F0-B4EAA8EDBBE9 Q57174881-91316DE2-62CD-4847-B98A-9F19F2C4373A

P2860

Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule

http://www.wikidata.org/entity/Q34173426

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Doxorubicin downregulates cell ...... as an anti-apoptotic molecule

@ast

Doxorubicin downregulates cell ...... as an anti-apoptotic molecule

@en

Doxorubicin downregulates cell ...... as an anti-apoptotic molecule

@nl

type

label

Doxorubicin downregulates cell ...... as an anti-apoptotic molecule

@ast

Doxorubicin downregulates cell ...... as an anti-apoptotic molecule

@en

Doxorubicin downregulates cell ...... as an anti-apoptotic molecule

@nl

prefLabel

Doxorubicin downregulates cell ...... as an anti-apoptotic molecule

@ast

Doxorubicin downregulates cell ...... as an anti-apoptotic molecule

@en

Doxorubicin downregulates cell ...... as an anti-apoptotic molecule

@nl

P1433

Q34173426-9285C791-BAE2-40BF-A00A-59DCC747D286

P1476

Q34173426-57724CC7-6531-43A8-8DD4-1311DA4A46FE

P2093

Q34173426-0A90BBCC-7D04-4448-80FE-9643C9D3EDD4

Q34173426-0C7252A2-A617-451C-9FE0-CD385E38D07D

Q34173426-294BF286-2944-4F29-8B15-42E15675E4A8

Q34173426-526DACBD-3AF2-480C-973F-E8E7D8DE78D0

Q34173426-5485B7C4-783B-4620-A407-8B1146BBD070

Q34173426-85A1005B-52D7-40CF-A9F0-A3B250B1DBEE

Q34173426-A61A7D6F-2918-46C9-802B-35A125F6C4E1

Q34173426-CA823F67-7A6E-4A02-906F-134971E30491

Q34173426-D142A2AB-79E1-4B51-8E6B-2BE4DF4479C2

Q34173426-F91492A5-7656-4470-A5E9-999FD781FD45

P2860

Q34173426-08AD1168-FE3A-442B-8D1A-9181519E18FC

Q34173426-094B769C-23B1-446C-AFD2-33903F6C3645

Q34173426-0B1C335A-58EA-435C-B810-A58304487B41

Q34173426-0D6D2ACE-9192-482C-8BCA-50C83849AB8F

Q34173426-10D021C1-E636-45D1-8DA1-9D243AFE5B44

Q34173426-11249231-B088-4E38-B6EC-CAE259B92A11

Q34173426-154F3DC7-B5A8-4F5B-B064-F052E5AB11D5

Q34173426-270CC64E-002B-45A8-B40B-4E436F750E4D

Q34173426-29735EFF-64FD-427D-B324-60920418A5E0

Q34173426-2A84B566-E64E-4A0D-BCB2-C65051597636

P2888

Q34173426-4CF344CD-A6FC-417B-BC99-FF304A7A1B36

P304

Q34173426-F1D43FAE-5844-4447-92BC-85B0372EDA87

P31

Q34173426-5AE833A5-5B29-4669-8B87-BE639546CDF7

P356

Q34173426-D1AB6E34-1B39-4D85-B517-07815F77ECAD

P433

Q34173426-A9465319-8EDA-478C-BE28-C628665F1D7F

P478

Q34173426-88699E86-3B92-49D6-B332-D0BD2346CCC7

P50

Q34173426-6873A0EA-1AFE-435E-9366-8598C7EC7EB5

P577

Q34173426-24B1A1C0-02D8-4F89-B1DB-0ACC682F4CD6

P5875

Q34173426-6F630481-F6FA-4185-90B1-FC91BA0FDCE7

P6179

Q34173426-CAAF6717-BEDF-4C10-B5D7-08EB04BA2B68

P698

Q34173426-52CEA958-4BAA-4F64-A1EF-CFC335A51D98

P921

Q34173426-F4082C90-3A70-4A17-8F49-9D24DBBC3507

P932

Q34173426-D0EC05C3-843D-4F4A-9086-5334FC3CF66E

P356

P1433

Breast Cancer Research

P1476

Doxorubicin downregulates cell ...... as an anti-apoptotic molecule

@en

P2093

Abdelilah Aboussekhra

http://www.w3.org/2001/XMLSchema#string

Asma Tulbah

http://www.w3.org/2001/XMLSchema#string

Ayodele Alaiya

http://www.w3.org/2001/XMLSchema#string

Cynthia Lehe

http://www.w3.org/2001/XMLSchema#string

Eman Barhoush

http://www.w3.org/2001/XMLSchema#string

Hazem Ghebeh

http://www.w3.org/2001/XMLSchema#string

Khaldoon Al-Romaih

http://www.w3.org/2001/XMLSchema#string

Monther Al-Alwan

http://www.w3.org/2001/XMLSchema#string

Pulicat Manogaran

http://www.w3.org/2001/XMLSchema#string

Siti-Faujiah Hendrayani

http://www.w3.org/2001/XMLSchema#string

P2860

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

HuR regulates p21 mRNA stabilization by UV light

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells.

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

The anthracyclines: will we ever find a better doxorubicin?

Calreticulin exposure dictates the immunogenicity of cancer cell death

Specificity and mechanism of action of some commonly used protein kinase inhibitors

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

P2888

P304

R48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2605

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45184127

http://www.w3.org/2001/XMLSchema#string

P6179

1008970191

http://www.w3.org/2001/XMLSchema#string

P698

20626886

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

2949635

http://www.w3.org/2001/XMLSchema#string